Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
DISEASE ACTIVITY ASSESSMENT USING THE DAS28, CDAI AND SDAI AND EFFECT OF ANTI-DRUG ANTIBODY ON CLINICAL RESPONSE IN A RANDOMIZED, DOUBLE-BLIND, COMPARATIVE TRIAL OF CT-P13 AND INNOVATOR INFLIXIMAB: PLANETRA STUDY
- Authors
- Yoo, D. -H.; Park, W.; Brzosko, M.; Geher, P.; Andersone, D.; Jaworski, J.; Rekalov, D.; Oparanov, B.; Kausiene, R.; Pacheco-Tena, C.; Lee, S.
- Issue Date
- Jun-2014
- Publisher
- BMJ PUBLISHING GROUP
- Citation
- 15th Annual European Congress of Rheumatology (EULAR), pp.235
- Conference Name
- 15th Annual European Congress of Rheumatology (EULAR)
- Place
- UK
Paris, FRANCE
- Conference Date
- 2014-06-11
- ISSN
- 0003-4967
- Files in This Item
- Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.